Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reactive oxygen species (ROS) and lipid radicals in lipophilic compartments refer to highly reactive chemical entities, such as lipid peroxyl (LOO•) and alkoxyl (LO•) radicals, that reside within cellular and organelle membranes. These species are primarily generated through the oxidation of polyunsaturated fatty acids (PUFAs), initiating a self-propagating chain reaction known as lipid peroxidation (Source: PubMed, PMID: 27556043). The uncontrolled accumulation of these lipophilic radicals is the defining hallmark of ferroptosis, an iron-dependent form of regulated cell death implicated in neurodegeneration, cancer, and organ injury (Source: Nature Chemical Biology, PMID: 22634314). Pharmacological targeting of these species involves the use of lipophilic radical-trapping antioxidants (RTAs) and ferroptosis inhibitors, such as Ferrostatin-1 and Liproxstatin-1, which localize to the lipid bilayer to terminate radical chain reactions (Source: Journal of Medicinal Chemistry, PMID: 30199244). While these radicals can participate in normal cell signaling at low levels, their overproduction leads to catastrophic loss of membrane integrity and cellular function. Consequently, neutralizing these species is a major therapeutic strategy for mitigating oxidative damage in various pathological states (Source: Cell, PMID: 25242330).
Radical scavenging and chain-breaking antioxidant activity within lipid bilayers to terminate lipid peroxidation and prevent membrane damage.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species and lipid radicals in lipophilic compartments (ROS/Lipid Radicals).